Compare Autodesk Inc (ADSK) vs Novartis AG (NVS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Autodesk Inc vs Novartis AG — how do they compare? Autodesk Inc trades at $206.41 (market cap $44.84B), while Novartis AG trades at $155.41 (market cap $298.98B). The key difference: Novartis AG is far larger — about 6.7× Autodesk Inc's market cap, and Novartis AG pays a 3.02% dividend while Autodesk Inc pays none. Which is the better fit depends on your goals.
| ADSK | NVS | |
|---|---|---|
Market Cap | $44.84B | $298.98B |
Sector | Technology | Health |
52-Week High | $326.79 | $168.62 |
52-Week Low | $187.72 | $113.50 |
Enterprise Value | $44.64B | $339.00B |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
